Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-14 4:26 pm Sale | 13G | AYALA PHARMACEUTICALS, INC. CO ADXS | Redmile Group LLC | 211,014 1.900% | -121,339 (-36.51%) | View |
2024-02-12 11:58 am Sale | 13D | AYALA PHARMACEUTICALS, INC. CO ADXS | Israel Biotech Fund I L.P. | 45,792,542 71.630% | -4,947,327 (-9.75%) | View |
2024-02-12 08:27 am Unchanged | 13G | AYALA PHARMACEUTICALS, INC. CO ADXS | Schindel Yair Chaim | 560,602 1.310% | 0 (Unchanged) | View |
2023-11-21 09:00 am Purchase | 13D | AYALA PHARMACEUTICALS, INC. CO ADXS | Israel Biotech Fund I L.P. | 50,739,869 83.600% | 47,060,869 (+1279.18%) | View |
2023-10-31 07:05 am Purchase | 13D | AYALA PHARMACEUTICALS, INC. CO ADXS | Israel Biotech Fund I L.P. | 3,679,000 28.000% | 1,318,616 (+55.86%) | View |
2023-10-23 06:45 am Unchanged | 13G | AYALA PHARMACEUTICALS, INC. CO ADXS | Schindel Yair Chaim | 560,602 5.210% | 0 (Unchanged) | View |
2023-09-11 12:38 pm Purchase | 13D | AYALA PHARMACEUTICALS, INC. CO ADXS | Israel Biotech Fund I L.P. | 2,360,384 35.900% | 2,360,384 (New Position) | View |
2023-02-08 5:18 pm Purchase | 13G | AYALA PHARMACEUTICALS, INC. CO ADXS | Redmile Group LLC | 332,353 6.800% | 332,353 (New Position) | View |
2023-01-30 06:01 am Purchase | 13G | AYALA PHARMACEUTICALS, INC. CO ADXS | Schindel Yair Chaim | 560,602 12.200% | 560,602 (New Position) | View |
2022-02-10 3:22 pm Sale | 13G | AYALA PHARMACEUTICALS, INC. CO ADXS | RENAISSANCE TECHNOLOGIES LLC | 0 0.000% | -6,069,343 (Position Closed) | View |
2021-02-16 09:52 am Sale | 13G | AYALA PHARMACEUTICALS, INC. CO ADXS | CVI Investments Inc. | 2,000,000 2.100% | -3,000,000 (-60.00%) | View |
2021-02-11 10:24 am Purchase | 13G | AYALA PHARMACEUTICALS, INC. CO ADXS | RENAISSANCE TECHNOLOGIES LLC | 6,069,343 6.500% | 2,289,260 (+60.56%) | View |
2020-08-03 4:03 pm Purchase | 13G | AYALA PHARMACEUTICALS, INC. CO ADXS | Lincoln Park Capital Fund LLC | 4,594,793 6.940% | 4,594,793 (New Position) | View |
2020-02-14 4:30 pm Sale | 13G | AYALA PHARMACEUTICALS, INC. CO ADXS | Anson Funds Management LP | 0 0.000% | -600,000 (Position Closed) | View |
2020-02-13 4:06 pm Sale | 13G | AYALA PHARMACEUTICALS, INC. CO ADXS | Altium Capital Management LP | 0 0.000% | -2,142,750 (Position Closed) | View |
2020-02-13 09:27 am Purchase | 13G | AYALA PHARMACEUTICALS, INC. CO ADXS | RENAISSANCE TECHNOLOGIES LLC | 3,780,083 7.530% | 3,780,083 (New Position) | View |
2020-01-30 10:05 am Purchase | 13G | AYALA PHARMACEUTICALS, INC. CO ADXS | CVI Investments Inc. | 5,000,000 8.300% | 5,000,000 (New Position) | View |
2020-01-21 11:38 am Sale | 13G | AYALA PHARMACEUTICALS, INC. CO ADXS | Empery Asset Management LP | 0 0.000% | -600,000 (Position Closed) | View |
2020-01-06 3:09 pm Sale | 13G | AYALA PHARMACEUTICALS, INC. CO ADXS | SABBY MANAGEMENT LLC | 0 0.000% | -600,000 (Position Closed) | View |